Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Olympus Corp ADR
(OP:
OCPNY
)
N/A
UNCHANGED
Last Price
Updated: 2:34 PM EST, Jan 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Olympus Corp ADR
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
March 27, 2024
From
Olympus
Via
JCN Newswire
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd
January 24, 2024
From
Olympus
Via
JCN Newswire
Olympus Names Dr. John de Csepel as Chief Medical Officer
October 03, 2023
From
Olympus
Via
JCN Newswire
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases
July 19, 2023
From
Olympus
Via
JCN Newswire
Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision
June 05, 2023
From
Olympus
Via
JCN Newswire
Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer
May 29, 2023
From
Olympus
Via
JCN Newswire
Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd
February 24, 2023
From
Olympus
Via
JCN Newswire
Olympus Named to Dow Jones Sustainability World Index for Two Consecutive Years
December 15, 2022
From
Olympus
Via
JCN Newswire
Olympus Announces Launch of Olympus Asia Pacific Innovation Program
December 04, 2022
From
Olympus
Via
JCN Newswire
Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam
December 06, 2022
Via
JCN Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.